• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Parasite load decrease during application of a safe and easily applied antileishmanial aminoglycoside cream.

作者信息

Ben Salah Afif, Zaâtour Amor, Ben Messaoud Nathalie, Kidar Abdelhamid, Smith Philip L, Kopydlowski Karen M, Kreishman-Deitrick Mara, Nielsen Carl J, Novitt-Moreno Anne, Ransom Janet H, Morizot Gloria, Grogl Max, Buffet Pierre A

机构信息

Institut Pasteur de Tunis, Tunis, Tunisia.

Regional Hospital of Gafsa, Gafsa, Tunisia.

出版信息

PLoS Negl Trop Dis. 2014 May 22;8(5):e2749. doi: 10.1371/journal.pntd.0002749. eCollection 2014 May.

DOI:10.1371/journal.pntd.0002749
PMID:24853096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4031053/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc6/4031053/f5619f01cdf3/pntd.0002749.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc6/4031053/f5619f01cdf3/pntd.0002749.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fc6/4031053/f5619f01cdf3/pntd.0002749.g001.jpg

相似文献

1
Parasite load decrease during application of a safe and easily applied antileishmanial aminoglycoside cream.在使用一种安全且易于涂抹的抗利什曼原虫氨基糖苷类乳膏期间，寄生虫负荷降低。
PLoS Negl Trop Dis. 2014 May 22;8(5):e2749. doi: 10.1371/journal.pntd.0002749. eCollection 2014 May.
2
Synthesis and biological evaluation of chalcones as potential antileishmanial agents.作为潜在抗利什曼原虫剂的查耳酮的合成与生物学评价
Eur J Med Chem. 2014 Jun 23;81:359-66. doi: 10.1016/j.ejmech.2014.05.034. Epub 2014 May 13.
3
Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.负载两性霉素B的乳滴脂质体对实验性内脏利什曼病的抗利什曼原虫疗效
J Drug Target. 2007 Jul;15(6):437-44. doi: 10.1080/10611860701453836.
4
Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.2010年内脏利什曼病的治疗：来自印度比哈尔邦的指导意见。
Future Microbiol. 2010 Sep;5(9):1301-3. doi: 10.2217/fmb.10.92.
5
Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India.印度一名接受注射用巴龙霉素治疗内脏利什曼病的患者出现了黑热病后皮肤利什曼病。
J Clin Microbiol. 2012 Apr;50(4):1478-9. doi: 10.1128/JCM.05966-11. Epub 2012 Jan 25.
6
Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in vitro and in vivo studies.乳铁蛋白修饰的载两性霉素B纳米储库对内脏利什曼病的靶向化疗：体外和体内研究
Nanomedicine (Lond). 2015;10(7):1093-109. doi: 10.2217/nnm.14.182.
7
A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study.内脏利什曼病化疗、免疫疗法及免疫化疗疗效的比较评估——一项实验研究
Parasitol Int. 2014 Aug;63(4):612-20. doi: 10.1016/j.parint.2014.04.002. Epub 2014 Apr 18.
8
Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.甘露糖硫醇化帕莫霉素载 PLGA 纳米粒口服治疗内脏利什曼病。
Nanomedicine (Lond). 2019 Feb;14(4):387-406. doi: 10.2217/nnm-2018-0038. Epub 2019 Jan 28.
9
Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.利用重点药物警戒确保孟加拉国国家黑热病消除规划中抗利什曼原虫药物的患者安全。
Infect Dis Poverty. 2018 Aug 13;7(1):80. doi: 10.1186/s40249-018-0461-0.
10
Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis.负载齐墩果酸的聚乳酸-乙醇酸-维生素E TPGS纳米颗粒用于治疗杜氏利什曼原虫感染的内脏利什曼病
Int J Biol Macromol. 2016 Dec;93(Pt A):961-970. doi: 10.1016/j.ijbiomac.2016.09.014. Epub 2016 Sep 17.

引用本文的文献

1
Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers.自行使用氨基糖苷类乳膏治疗旅行者皮肤利什曼病。
PLoS Negl Trop Dis. 2023 Aug 10;17(8):e0011492. doi: 10.1371/journal.pntd.0011492. eCollection 2023 Aug.
2
Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review.皮肤利什曼病的局部治疗的治疗进展：综述。
PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009099. doi: 10.1371/journal.pntd.0009099. eCollection 2021 Mar.
3
Walter Reed Army Institute of Research (WRAIR): Fifty Years of Achievements That Impact Science and Society.

本文引用的文献

1
Travelers with cutaneous leishmaniasis cured without systemic therapy.患有皮肤利什曼病的旅行者未经全身治疗而痊愈。
Clin Infect Dis. 2013 Aug;57(3):370-80. doi: 10.1093/cid/cit269. Epub 2013 Apr 30.
2
Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.局部使用巴龙霉素联合或不联合庆大霉素治疗皮肤利什曼病。
N Engl J Med. 2013 Feb 7;368(6):524-32. doi: 10.1056/NEJMoa1202657.
3
Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major.
沃尔特·里德陆军研究所（WRAIR）：五十载成就斐然，影响科学与社会。
Mil Med. 2021 Feb 26;186(3-4):72-77. doi: 10.1093/milmed/usaa468.
4
Psycho-social impacts, experiences and perspectives of patients with Cutaneous Leishmaniasis regarding treatment options and case management: An exploratory qualitative study in Tunisia.《突尼斯一项探索性定性研究：关于治疗方案和病例管理，皮肤病利什曼病患者的心理社会影响、经历和观点》。
PLoS One. 2020 Dec 1;15(12):e0242494. doi: 10.1371/journal.pone.0242494. eCollection 2020.
5
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis.皮肤利什曼病新药和疗法的发现和临床前开发的路线图。
Int J Parasitol Drugs Drug Resist. 2019 Dec;11:106-117. doi: 10.1016/j.ijpddr.2019.06.003. Epub 2019 Jun 20.
6
Microneedle-Based Delivery of Amphotericin B for Treatment of Cutaneous Leishmaniasis.基于微针的两性霉素B递送用于治疗皮肤利什曼病
Biomed Microdevices. 2019 Jan 7;21(1):8. doi: 10.1007/s10544-018-0355-8.
7
Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.脂质体两性霉素B治疗皮肤和黏膜皮肤利什曼病旅行者：并非万灵药。
PLoS Negl Trop Dis. 2017 Nov 20;11(11):e0006094. doi: 10.1371/journal.pntd.0006094. eCollection 2017 Nov.
8
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.五价锑酸盐病灶内注射疗法治疗皮肤利什曼病的疗效：一项系统评价。
PLoS One. 2017 Sep 19;12(9):e0184777. doi: 10.1371/journal.pone.0184777. eCollection 2017.
在庆大霉素压力下减毒的硕大利什曼原虫H株，可诱导Th1反应，从而保护易感的BALB/c小鼠免受强毒力硕大利什曼原虫的感染。
Parasitology. 2009 Sep;136(11):1243-50. doi: 10.1017/S0031182009990679. Epub 2009 Aug 3.
4
WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study.WR279,396，第三代氨基糖苷类软膏治疗皮肤利什曼病：一项 2 期、随机、双盲、安慰剂对照研究。
PLoS Negl Trop Dis. 2009;3(5):e432. doi: 10.1371/journal.pntd.0000432. Epub 2009 May 5.
5
Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan.毁容性利什曼病：巴基斯坦和阿富汗皮肤利什曼病的污名化及影响
PLoS Negl Trop Dis. 2008;2(10):e259. doi: 10.1371/journal.pntd.0000259. Epub 2008 Oct 29.
6
Injectable paromomycin for Visceral leishmaniasis in India.印度用于治疗内脏利什曼病的注射用巴龙霉素
N Engl J Med. 2007 Jun 21;356(25):2571-81. doi: 10.1056/NEJMoa066536.
7
Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.用巴龙霉素（氨基糖苷）和庆大霉素联合成功局部治疗小鼠皮肤利什曼病。
J Parasitol. 1999 Apr;85(2):354-9.
8
Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience.静脉注射葡萄糖酸锑钠治疗利什曼病的安全性和有效性：美国军方近期经验
Clin Infect Dis. 1998 Dec;27(6):1457-64. doi: 10.1086/515027.
9
Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice.培养微量滴定法：一种用于定量检测感染小鼠组织中婴儿利什曼原虫的灵敏方法。
Antimicrob Agents Chemother. 1995 Sep;39(9):2167-8. doi: 10.1128/AAC.39.9.2167.
10
The sensitivity of Leishmania species to aminosidine.利什曼原虫属对氨基糖苷的敏感性。
J Antimicrob Chemother. 1995 May;35(5):577-84. doi: 10.1093/jac/35.5.577.